Gary Peters is trending on Google today, not because of a bill he passed, not because of a floor speech, and not because of anything his office put out. He's trending because he's leaving. The Michigan senator announced he wouldn't seek re-election, his seat is now a marquee pickup target, and the chatter about who fills it has drowned out almost everything else about the man who still holds it. While the political class sorts out the succession, Peters has been doing something quieter: trading stocks. Three of them, all on the same day, one of which lands directly in the jurisdiction of a committee he sits on.
The Seat, the Race, and Why Peters Is in the Feed
Peters announced he'd retire at the end of this term, opening one of the more consequential Senate seats on the 2026 map. Michigan is a genuine swing state, and the race to replace him has already generated endorsement drama. Posts circulating on Bluesky this week reference Peters's endorsement of Haley Stevens in the Democratic primary, which has energized supporters of Abdul El-Sayed as a counterargument. The August 4th primary is live. The seat is genuinely in play.
Peters still votes. He still sits on his committees. He still files disclosures. And in the last 90 days, he filed three of them.
Three Trades. One Day. One Committee Problem.
On April 23, 2026, Peters disclosed a sale of Corteva (CTVA) in the $15,000–$50,000 range, a purchase of J.M. Smucker (SJM) in the $1,000–$15,000 range, and a purchase of PepsiCo (PEP) in the $15,000–$50,000 range. All three on the same date. All three in the food and consumer staples space.
Corteva makes seeds and crop protection products. Its revenues move with farm bill appropriations, EPA pesticide regulations, and USDA trade exposure. Peters sits on the Senate Appropriations Committee's Agriculture, Rural Development, Food and Drug Administration, and Related Agencies subcommittee. That's the same lane. The CTVA sale carries a committee overlap flag in Blind Trust's scoring data.
So does the PEP purchase, flagged under Food and Beverage/Consumer. PepsiCo operates under FDA labeling rules, interacts with USDA commodity programs, and has lobbied on nutrition policy for years. Peters's subcommittee has appropriations authority over both the FDA and the USDA. The Venn diagram is not two separate circles.
The Smucker position is the smallest of the three — $1,000–$15,000. Smucker makes jam and coffee. Decide for yourself how close those worlds touch.
The Alpha Record: Not a Winning Streak
Of Peters's 9 scored trades in the Blind Trust record, 5 were positive and 4 were negative. His mean 30-day alpha sits at negative 3.4 percent — a coin flip with a downward lean.
The best trades on record: a January 2026 purchase of Stanley Black and Decker (SWK) that produced 9.2 percent 30-day alpha, a W.P. Carey (WPC) purchase from the same date that generated 7.3 percent, and a Conagra Brands (CAG) buy from November 2025 that returned 3.8 percent. None of those three carry a committee overlap flag.
The worst: the CTVA sale, negative 5.6 percent 30-day alpha, committee overlap tagged Agriculture. An Intel (INTC) sale from December 2025 — $15,000–$50,000 — at negative 5.8 percent, flagged for Technology overlap. And an Organon (OGN) sale from October 2025 at negative 39.9 percent, the single worst result in the set, with no committee overlap. That last one cost Peters on paper regardless of anything else going on.
Two of his four losing trades carried committee overlap designations. The positions where his legislative seat is most relevant to his portfolio are also the ones that have underperformed. Whether that's coincidence, bad timing, or just the universe's indifference to irony is not something a disclosure filing can tell you.
The Votes Running Parallel
Peters has been active on the floor this summer. On July 16th, he voted Yea on a motion to proceed on S.J.Res. 198, a joint resolution to disapprove a CMS rule implementing prior authorization requirements under the WISeR model for Medicare. The motion was rejected. Peters has no healthcare committee assignment, so there's no conflict angle — he's voting on Medicare policy as a floor member, same as most of the chamber.
On July 14th, Peters voted Nay on a motion to invoke cloture on the National Defense Authorization Act for Fiscal Year 2027. Peters sits on Armed Services and three of its subcommittees — Airland, Cybersecurity, and Emerging Threats and Capabilities. A Nay vote on the NDAA from an Armed Services member is a notable posture. No trades in defense names appear in the recent 90-day window, so there's no overlap to trace there.
Peters voted Yea three separate times on the 21st Century ROAD to Housing Act in June, including the final motion on June 22nd. He also voted Yea on two Iran-related War Powers resolutions that same week. None of those votes show trade overlaps in the data.
The CTVA sale remains the sharpest intersection in the recent record: a sale in an ag-sector company, filed the same day as two other trades, by a senator who appropriates money to the USDA and FDA.
The System, As Designed
Members of the Senate are required to disclose their trades. They are not required to divest, recuse, abstain, or explain. Peters's office has not commented on the trades. The STOCK Act requires disclosure within 45 days of a transaction. It does not require members to consider whether the company they're selling has a lobbying presence in their subcommittee's jurisdiction.
Corteva has regulatory exposure to the same federal agencies whose budgets Peters's subcommittee controls. The trade lost value over the following 30 days. That doesn't touch the legality. The legality is fine — and that's the part worth sitting with.
His full trading record is public at Blind Trust: 9 scored trades, 5 positive, 4 negative, negative 3.4 percent mean alpha, two losing trades with committee overlap flags in Agriculture and Technology. The portfolio doesn't paint a picture of someone running a sophisticated hedge. It paints a picture of a retiring senator whose investments happen to touch the same industries his committee oversees.
Peters is in the news because his seat is open and Michigan matters. His financial record is in the database because the law says it has to be. The receipts are public. Make of them what you make of them.